Maskarinec G, Pagano I, Chen Z, Nagata C, Gram IT. Ethnic and geographic differences in mammography density and their association with breast cancer incidence. Breast Cancer Res Treat. 2007;104:47–56.
Suzuki A, Kuriyama S, Kawai M, Amari M, Takebe M, Ishida T, et al. Age-specific interval breast cancers in Japan: estimation of the proper sensitivity of screening using a population-based cancer registry. Cancer Sci. 2008;99:2264–7.
Article PubMed CAS Google Scholar
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, U.S. Preventive services Task Force. Screening for breast cancer; an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37.
Article PubMed PubMed Central Google Scholar
Hori M, Matsuda T, Shibata A, Katanoda K, Sobue T, Nishimoto H, Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45(9):884–91.
Ohuchi N, Ishida T, Kawai M, Narikawa Y, Yamamoto S, Sobue T. Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40–49 (J-START): research design. Jpn J Clin Oncol. 2011;41(2):275–7.
Ishida T, Suzuki A, Kawai M, Narikawa Y, Saito H, Yamamoto S, et al. A randomized controlled trial to verify the efficacy of the use of ultrasonography in breast cancer screening aged 40–49 (J-START): 76 196 women registered. Jpn J Clin Oncol. 2014;44(2):134–40.
Ohuchi N, Suzuki A, Sobue T, Kawai M, Yamamoto S, Zheng YF, J-START Investigator Groups, et al. Sensitivity and specificity of mammography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomized controlled trial. Lancet. 2016;387(10016):341–8.
Ohnuki K, Tsunoda H, Tohno E, Iisato U, Powa M, Obane N, The Study Group for Breast Cancer Screening in Japan Association of Breast and Thyroid Sonology, et al. The criteria for mammography screening combined with ultrasonography. Jpn Assoc Breast Cancer Screen. 2012;21(3):273–9.
Ohnuki K, Tohno E, Tsunoda H, Uematasu T, Nakajima Y. Overall assessment system of combined mammography and ultrasound for breast cancer screening. Breast Cancer. 2021;28:254–62.
The combined Assessment Committee of the Japan Association of Breast Cancer Screening. The overall assessment manual for combined screening of mammography and ultrasound. Tokyo: Shinoharashinsha; 2015.
Ohnuki K, Tsunoda H, Tohno E, Iisato U, Oiwa M, Obane N, The Study Group for Breast Cancer Screening in Japan Association of Breast and Thyroid Sonology, et al. The criteria for mammography screening combined with ultrasonography (Japanese). Tokyo: Shinoharashinsha; 2015.
Uematsu T, Oiwa M, Okanami Y, Tohno E, Noma M, Miyagi Y. What is the difference of combined assessment with mammography and ultrasound between breast cancer screening and diagnostic breast imaging examination? Jpn Assoc Breast Cancer Screen. 2018;27(2):119–24.
Suzuki S, Tsunoda H, Kawakami M, Hasegawa H, Yonetsu K, Oyama Y, et al. Evaluation of the recall criteria for breast cancer screening combined with mammography and ultrasonography. Jpn Assoc Breast Cancer Screen. 2013;22(1):115–22.
Souma A, Ohnuki K, Usami S, Miura Y, Sasaki K, Sekimura N, et al. Practice of overall assessment of breast cancer screening combined with mammography and ultrasonography. Jpn Assoc Breast Cancer Screen. 2016;25(2):160–2.
Ito N, Yoshimura R, Mori T, Nagano Y, Kamei A, Sou E, et al. Study on breast density-focused breast cancer screening combining mammography and ultrasonography. Ningen Dock. 2017;32:469–75.
Usami S, Ohnuki K, Watanabe M, Umemura A, Takagi M, Asano S, et al. Current status and problems of simultaneous screening with mammography and ultrasound. Jpn Assoc Breast Cancer Screen. 2018;27(1):51–5.
Japan Radiology Society/Japan Society of Radiological Technology. Mammography guideline. Tokyo: Igaku-Shoin Ltd; 2021.
Tohno E, Umemoto T, Sasaki K, Morishima I, Ueno E. Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates; a retrospective study in Japan. Eur J Radiol. 2013;82:1227–30.
Harada-Shoji N, Suzuki A, Ishida T, Zheng YF, Narikawa-Shiono Y, Sato-Tadano A, et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40–49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2021;4(8): e2121505.
Article PubMed PubMed Central Google Scholar
National Cancer Center: https://ganjoho.jp/reg_stat/statistics/stat/screening/process-indicator.html. 20 Aug 2023
Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998–2005.
Article PubMed CAS Google Scholar
Miller AB, Wall C, Baines CJ, Sun P, To T, Narod SA. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial. BMJ. 2014;348: g366.
Article PubMed PubMed Central Google Scholar
Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ. 2006;332(7543):689–92.
Article PubMed PubMed Central Google Scholar
Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778–86.
Tadaoki M, Yoshio K, Hiroko T, Tangoku A. Measures for reducing over-diagnosis in breast cancer screening. Jpn Assoc Breast Cancer Screen. 2014;23(3):337–46.
Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med. 1997;127:1023–8.
Comments (0)